Myogenic potential of mesenchymal stem cells - The case of adhesive fraction of human umbilical cord blood cells

Current Stem Cell Research and Therapy

Volumn 8, Issue 1, 2013, Pages 82-90

  Grabowska, Iwona ^a   Streminska, Wladyslawa ^a   Janczyk Ilach, Katarzyna ^a   Machaj, Eugeniusz K ^b,c   Pojda, Zygmunt ^b,c   Hoser, Grazyna ^d   Kawiak, Jerzy ^d   Moraczewski, Jerzy ^a   Ciemerych, Maria A ^a   Brzoska, Edyta ^a  

^a UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c MILITARY INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Poland)

^d MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Human umbilical cord blood; Mesenchymal stem cells; Myogenesis; Regeneration

Indexed keywords

ALPHA3 INTEGRIN; BETA1 INTEGRIN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CXCR4; MYOGENIC FACTOR; MYOGENIN; STROMAL CELL DERIVED FACTOR 1;

ANIMAL TISSUE; ARTICLE; BLOOD CELL; CELL MIGRATION; CELL TRANSPLANTATION; CONTROLLED STUDY; HUMAN; IMMUNODETECTION; IMMUNOLOCALIZATION; MESENCHYMAL STEM CELL; MOUSE; MUSCLE INJURY; MUSCLE MASS; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PLURIPOTENT STEM CELL; PRECURSOR; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UMBILICAL CORD BLOOD;

ADULT; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FETAL BLOOD; HUMANS; IMMUNOENZYME TECHNIQUES; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOGENIC REGULATORY FACTORS; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; REGENERATIVE MEDICINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84879749960     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X11308010010     Document Type: Article

References (112)

1. Yablonka-Reuveni Z. The skeletal muscle satellite cell: still young and fascinating at 50. J Histochem Cytochem 2011; 59(12): 1041-59.
2. Scharner J, Zammit PS. The muscle satellite cell at 50: the formative years. Skelet Muscle 2011; 1(1): 28.
3. Ciciliot S, Schiaffino S. Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications. Curr Pharm Des 2010; 16(8): 906-14.
4. Brzoska E, Ciemerych MA, Przewozniak M, Zimowska M. Regulation of muscle stem cells activation: the role of growth factors and extracellular matrix. Vitam Horm 2011; 87: 239-76.
5. Chazaud B, Brigitte M, Yacoub-Youssef H, et al. Dual and beneficial roles of macrophages during skeletal muscle regeneration. Exerc Sport Sci Rev 2009; 37(1): 18-22.
6. Zammit PS. All muscle satellite cells are equal, but are some more equal than others? J Cell Sci 2008; 121(Pt 18): 2975-82.
7. Perez-Ruiz A, Ono Y, Gnocchi VF, Zammit PS. beta-Catenin promotes self-renewal of skeletal-muscle satellite cells. J Cell Sci 2008; 121(Pt 9): 1373-82.
8. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA. Pax7 is required for the specification of myogenic satellite cells. Cell 2000; 102(6): 777-86.
9. Zammit PS, Partridge TA, Yablonka-Reuveni Z. The skeletal muscle satellite cell: the stem cell that came in from the cold. J Histochem Cytochem 2006; 54(11): 1177-91.
10. Zammit PS, Heslop L, Hudon V, et al. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp Cell Res 2002; 281(1): 39-49.
11. Zammit PS, Golding JP, Nagata Y, Hudon V, Partridge TA, Beauchamp JR. Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? J Cell Biol 2004; 166(3): 347-57.
12. Yablonka-Reuveni Z, Rivera AJ. Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers. Dev Biol 1994; 164(2): 588-603.
13. McKinnell IW, Ishibashi J, Le Grand F, et al. Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex. Nat Cell Biol 2008; 10(1): 77-84.
14. Pavlath GK. Spatial and functional restriction of regulatory molecules during mammalian myoblast fusion. Exp Cell Res 2010; 316(18): 3067-72.
15. Brzoska E, Bello V, Darribere T, Moraczewski J. Integrin alpha3 subunit participates in myoblast adhesion and fusion in vitro. Differentiation 2006; 74(2-3): 105-18.
16. Lafuste P, Sonnet C, Chazaud B, et al. ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation. Mol Biol Cell 2005; 16(2): 861-70.
17. Zhao Z, Gruszczynska-Biegala J, Cheuvront T, et al. Interaction of the disintegrin and cysteine-rich domains of ADAM12 with integrin alpha7beta1. Exp Cell Res 2004; 298(1): 28-37.
18. Wrobel E, Brzoska E, Moraczewski J. M-cadherin and beta-catenin participate in differentiation of rat satellite cells. Eur J Cell Biol 2007; 86(2): 99-109.
19. Collins CA, Olsen I, Zammit PS, et al. Stem cell function, selfrenewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005; 122(2): 289-301.
20. Sampaolesi M, Torrente Y, Innocenzi A, et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003; 301(5632): 487-92.
21. Galvez BG, Sampaolesi M, Brunelli S, et al. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J Cell Biol 2006; 174(2): 231-43.
22. Sampaolesi M, Blot S, D'Antona G, et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006; 444(7119): 574-9.
23. Guttinger M, Tafi E, Battaglia M, et al. Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice. Exp Cell Res 2006; 312(19): 3872-9.
24. Morosetti R, Gidaro T, Broccolini A, et al. Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior. Cell Transplant 2010.
25. Tanaka KK, Hall JK, Troy AA, Cornelison DD, Majka SM, Olwin BB. Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell 2009; 4(3): 217-25.
26. Zheng B, Cao B, Crisan M, et al. Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol 2007; 25(9): 1025-34.
27. Mitchell KJ, Pannerec A, Cadot B, et al. Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Nat Cell Biol 2010; 12(3): 257-66.
28. Dellavalle A, Sampaolesi M, Tonlorenzi R, et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 2007; 9(3): 255-67.
29. Torrente Y, Belicchi M, Sampaolesi M, et al. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 2004; 114(2): 182-95.
30. Gavina M, Belicchi M, Rossi B, et al. VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation. Blood 2006; 108(8): 2857-66.
31. Shi M, Ishikawa M, Kamei N, et al. Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells. Stem Cells 2009; 27(4): 949-60.
32. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999; 401(6751): 390-4.
33. De Bari C, Dell'Accio F, Vandenabeele F, Vermeesch JR, Raymackers JM, Luyten FP. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 2003; 160(6): 909-18.
34. Pojda Z. Use of non-hematopoietic stem cells of fetal origin from cord blood, umbilical cord and placenta in regeneration medicine. In: Bhattacharya N, Stubblefield P, editors. Regenerative Medicine Using Pregnancy-Specific Biological Substances. London: Springer-Verlag London Ltd; 2011. p. 283-95.
35. Kadivar M, Khatami S, Mortazavi Y, Shokrgozar MA, Taghikhani M, Soleimani M. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun 2006; 340(2): 639-47.
36. Ma L, Feng XY, Cui BL, et al. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nervelike cells. Chin Med J (Engl) 2005; 118(23): 1987-93.
37. Campard D, Lysy PA, Najimi M, Sokal EM. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008; 134(3): 833-48.
38. Anzalone R, Lo Iacono M, Loria T, et al. Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes. Stem Cell Rev 2011; 7(2): 342-63.
39. Grabowska I, Brzoska E, Gawrysiak A, et al. Restricted myogenic potential of mesenchymal stromal cells isolated from umbilical cord. Cell Transplant 2012; 21(8): 1711-26.
40. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13(12): 4279-95.
41. Toma JG, Akhavan M, Fernandes KJ, et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001; 3(9): 778-84.
42. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119(Pt 11): 2204-13.
43. Asakura A, Komaki M, Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001; 68(4-5): 245-53.
44. Anzalone R, Corrao S, Lo Iacono M, et al. Isolation and characterization of CD276+/HLA-E+ human sub-endocardial mesenchymal stem cells from chronic heart failure patients: analysis of differentiative potential and immunomodulatory markers expression. Stem Cells Dev 2013; 22(1): 1-17.
45. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284(5411): 143-7.
46. Hoogduijn MJ, Dor FJ. Mesenchymal stem cells in transplantation and tissue regeneration. Front Immunol 2011; 2: 84.
47. Hare JM, Traverse JH, Henry TD, et al. A randomized, doubleblind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009; 54(24): 2277-86.
48. Dahlke MH, Hoogduijn M, Eggenhofer E, et al. Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study group. Transplantation 2009; 88(5): 614-9.
49. Duijvestein M, Vos AC, Roelofs H, et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 2010; 59(12): 1662-9.
50. Freedman MS, Bar-Or A, Atkins HL, et al. The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Mult Scler 2010; 16(4): 503-10.
51. Meyer S, Yarom R. Muscle regeneration and transplantation enhanced by bone marrow cells. Br J Exp Pathol 1983; 64(1): 15-24.
52. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279(5356): 1528-30.
53. LaBarge MA, Blau HM. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 2002; 111(4): 589-601.
54. Camargo FD, Green R, Capetanaki Y, Jackson KA, Goodell MA. Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med 2003; 9(12): 1520-7.
55. Corbel SY, Lee A, Yi L, et al. Contribution of hematopoietic stem cells to skeletal muscle. Nature medicine 2003; 9(12): 1528-32.
56. Sherwood RI, Christensen JL, Weissman IL, Wagers AJ. Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells. Stem Cells 2004; 22(7): 1292-304.
57. Shi D, Reinecke H, Murry CE, Torok-Storb B. Myogenic fusion of human bone marrow stromal cells, but not hematopoietic cells. Blood 2004; 104(1): 290-4.
58. Dezawa M, Ishikawa H, Itokazu Y, et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 2005; 309(5732): 314-7.
59. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003; 21(1): 105-10.
60. Carvalho MM, Teixeira FG, Reis RL, Sousa N, Salgado AJ. Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. Curr Stem Cell Res Ther 2011; 6(3): 221-8.
61. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86(10): 3828-32.
62. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321(17): 1174-8.
63. Vormoor J, Lapidot T, Pflumio F, et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994; 83(9): 2489-97.
64. Wang JC, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997; 89(11): 3919-24.
65. Koestenbauer S, Zisch A, Dohr G, Zech NH. Protocols for hematopoietic stem cell expansion from umbilical cord blood. Cell Transplant 2009; 18(10): 1059-68.
66. Pesce M, Orlandi A, Iachininoto MG, et al. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ Res 2003; 93(5): e51-62.
67. Wu X, Lensch MW, Wylie-Sears J, Daley GQ, Bischoff J. Hemogenic endothelial progenitor cells isolated from human umbilical cord blood. Stem Cells 2007; 25(11): 2770-6.
68. Lin RZ, Dreyzin A, Aamodt K, Dudley AC, Melero-Martin JM. Functional endothelial progenitor cells from cryopreserved umbilical cord blood. Cell Transplant 2011; 20(4): 515-22.
69. Vanneaux V, El-Ayoubi F, Delmau C, et al. In vitro and in vivo analysis of endothelial progenitor cells from cryopreserved umbilical cord blood: are we ready for clinical application? Cell Transplant 2010; 19(9): 1143-55.
70. Kim JS, Lee HK, Kim MR, Kim PK, Kim CW. Differentially expressed proteins of mesenchymal stem cells derived from human cord blood (hUCB) during osteogenic differentiation. Biosci Biotechnol Biochem 2008; 72(9): 2309-17.
71. Sanchez-Ramos JR, Song S, Kamath SG, et al. Expression of neural markers in human umbilical cord blood. Exp Neurol 2001; 171(1): 109-15.
72. Zigova T, Song S, Willing AE, et al. Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain. Cell Transplant 2002; 11(3): 265-74.
73. Buzanska L, Jurga M, Stachowiak EK, Stachowiak MK, Domanska-Janik K. Neural stem-like cell line derived from a nonhematopoietic population of human umbilical cord blood. Stem Cells Dev 2006; 15(3): 391-406.
74. Buzanska L, Machaj EK, Zablocka B, Pojda Z, Domanska-Janik K. Human cord blood-derived cells attain neuronal and glial features in vitro. J Cell Sci 2002; 115(Pt 10): 2131-8.
75. Park DH, Borlongan CV, Willing AE, et al. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant 2009; 18(9): 985-98.
76. Herranz AS, Gonzalo-Gobernado R, Reimers D, Asensio MJ, Rodriguez-Serrano M, Bazan E. Applications of human umbilical cord blood cells in central nervous system regeneration. Curr Stem Cell Res Ther 2012; 5(1): 17-22.
77. Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO, Wall DA. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 2001; 7(11): 581-8.
78. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000; 109(1): 235-42.
79. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103(5): 1669-75.
80. Coenen M, Kogler G, Wernet P, Brustle O. Transplantation of human umbilical cord blood-derived adherent progenitors into the developing rodent brain. J Neuropathol Exp Neurol 2005; 64(8): 681-8.
81. Brzoska E, Grabowska I, Hoser G, et al. Participation of stem cells from human cord blood in skeletal muscle regeneration of SCID mice. Exp Hematol 2006; 34(9): 1262-70.
82. Ha SY, Jee BC, Suh CS, et al. Cryopreservation of human embryonic stem cells without the use of a programmable freezer. Hum Reprod 2005; 20(7): 1779-85.
83. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, Smith A. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from selfrenewal to lineage commitment. Development 2007; 134(16): 2895-902.
84. Tamaki T, Akatsuka A, Ando K, et al. Identification of myogenicendothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 2002; 157(4): 571-7.
85. Maitra N, Flink IL, Bahl JJ, Morkin E. Expression of alpha and beta integrins during terminal differentiation of cardiomyocytes. Cardiovasc Res 2000; 47(4): 715-25.
86. Abe E, Mocharla H, Yamate T, Taguchi Y, Manolagas SC. Meltrin-alpha, a fusion protein involved in multinucleated giant cell and osteoclast formation. Calcif Tissue Int 1999; 64(6): 508-15.
87. Aiuti A, Turchetto L, Cota M, et al. Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. Blood 1999; 94(1): 62-73.
88. Bajetto A, Barbieri F, Dorcaratto A, et al. Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochem Int 2006; 49(5): 423-32.
89. Lisignoli G, Toneguzzi S, Piacentini A, et al. Human osteoblasts express functional CXC chemokine receptors 3 and 5: activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and beta-N-acetylhexosaminidase release. J Cell Physiol 2003; 194(1): 71-9.
90. Zador E, Mendler L, Ver Heyen M, Dux L, Wuytack F. Changes in mRNA levels of the sarcoplasmic/endoplasmic-reticulum Ca(2+)-ATPase isoforms in the rat soleus muscle regenerating from notexin-induced necrosis. Biochem J 1996; 320 (Pt 1): 107-13.
91. Brzoska E, Przewozniak M, Grabowska I, Janczyk-Ilach K, Moraczewski J. Pax3 and Pax7 expression during myoblast differentiation in vitro and fast and slow muscle regeneration in vivo. Cell Biol Int 2009; 33(4): 483-92.
92. Suwinska A, Ciemerych MA. Factors regulating pluripotency and differentiation in early mammalian embryos and embryo-derived stem cells. Vitam Horm 2011; 87: 1-37.
93. Buckingham M, Vincent SD. Distinct and dynamic myogenic populations in the vertebrate embryo. Curr Opin Genet Dev 2009; 19(5): 444-53.
94. Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clin Genet 2000; 57(1): 16-25.
95. McDonald KA, Lakonishok M, Horwitz AF. Alpha v and alpha 3 integrin subunits are associated with myofibrils during myofibrillogenesis. J Cell Sci 1995; 108 (Pt 7): 2573-81.
96. Schwander M, Leu M, Stumm M, et al. Beta1 integrins regulate myoblast fusion and sarcomere assembly. Dev Cell 2003; 4(5): 673-85.
97. Donalies M, Cramer M, Ringwald M, Starzinski-Powitz A. Expression of M-cadherin, a member of the cadherin multigene family, correlates with differentiation of skeletal muscle cells. Proc Natl Acad Sci USA 1991; 88(18): 8024-8.
98. Kaufmann U, Kirsch J, Irintchev A, Wernig A, Starzinski-Powitz A. The M-cadherin catenin complex interacts with microtubules in skeletal muscle cells: implications for the fusion of myoblasts. J Cell Sci 1999; 112 (Pt 1): 55-68.
99. Hollnagel A, Grund C, Franke WW, Arnold HH. The cell adhesion molecule M-cadherin is not essential for muscle development and regeneration. Mol Cell Biol 2002; 22(13): 4760-70.
100. Galliano MF, Huet C, Frygelius J, Polgren A, Wewer UM, Engvall E. Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha-actinin-2, is required for myoblast fusion. J Biol Chem 2000; 275(18): 13933-9.
101. Kurisaki T, Masuda A, Osumi N, Nabeshima Y, Fujisawa-Sehara A. Spatially-and temporally-restricted expression of meltrin alpha (ADAM12) and beta (ADAM19) in mouse embryo. Mech Dev 1998; 73(2): 211-5.
102. Kucia M, Jankowski K, Reca R, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 2004; 35(3): 233-45.
103. Cohen Y, Nagler A. Cord blood biology and transplantation. Isr Med Assoc J 2004; 6(1): 39-46.
104. Newman MB, Davis CD, Kuzmin-Nichols N, Sanberg PR. Human umbilical cord blood (HUCB) cells for central nervous system repair. Neurotox Res 2003; 5(5): 355-68.
105. Madeddu P, Emanueli C, Pelosi E, et al. Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 2004; 18(14): 1737-9.
106. Koponen JK, Kekarainen T, Heinonen S, et al. Umbilical cord blood-derived progenitor cells enhance muscle regeneration in mouse hindlimb ischemia model. Mol Ther 2007; 15(12): 2172-7.
107. Kong KY, Ren J, Kraus M, Finklestein SP, Brown RH, Jr. Human umbilical cord blood cells differentiate into muscle in sjl muscular dystrophy mice. Stem Cells 2004; 22(6): 981-93.
108. Nunes VA, Cavacana N, Canovas M, Strauss BE, Zatz M. Stem cells from umbilical cord blood differentiate into myotubes and express dystrophin in vitro only after exposure to in vivo muscle environment. Biol Cell 2007; 99(4): 185-96.
109. Carlin R, Davis D, Weiss M, Schultz B, Troyer D. Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol 2006; 4: 8.
110. La Rocca G, Anzalone R, Corrao S, et al. Isolation and characterization of Oct-4(+)/HLA-G (+) mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 2009; 131(2): 267-82.
111. Brzoska E, Kowalewska M, Markowska-Zagrajek A, et al. Sdf-1 (CXCL12) improves skeletal muscle regeneration via the mobilisation of Cxcr4 and CD34 expressing cells. Biol Cell 2012; 104(12): 722-37.
112. Perez AL, Bachrach E, Illigens BM, et al. CXCR4 enhances engraftment of muscle progenitor cells. Muscle Nerve 2009; 40(4): 562-72.